Aduro Biotech (ADRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADRO | AMGN | GILD | VRTX | REGN |
| Company | Aduro Biotech | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.05 | 273.45 | 67.47 | 402.44 | 911.09 |
| High | 14.86 | 274.35 | 67.90 | 403.88 | 915.00 |
| Low | 13.92 | 267.24 | 65.09 | 393.00 | 876.75 |
| Last | 14.60 | 269.38 | 65.27 | 397.70 | 890.68 |
| Change | +0.59 | -3.63 | -1.81 | -3.06 | -15.86 |
| % Change | +4.18% | -1.33% | -2.70% | -0.76% | -1.75% |
| Volume | 171,500 | 1,794,000 | 15,171,900 | 787,600 | 576,500 |
| 20-Day Average Volume | 149,894 | 2,149,590 | 6,861,755 | 964,110 | 454,910 |
| Previous Close | 14.01 | 273.01 | 67.08 | 400.76 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.53 | 270.70 | 68.68 | 402.31 | 922.51 |
| 20-Day Raw Stochastic | 76.03% | 31.20% | 2.05% | 21.98% | 14.81% |
| 20-Day Relative Strength | 56.92% | 44.80% | 28.32% | 42.69% | 34.96% |
| Weighted Alpha | +96.00 | +9.12 | -23.73 | +14.87 | +11.12 |
| Today's Opinion | 40% Buy | 72% Sell | 100% Sell | 8% Buy | 8% Buy |
| Previous Opinion | 32% Buy | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 56% Buy | 24% Buy | 88% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.16% since 09/28/20 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | +1.07% since 04/18/24 | -0.37% since 04/18/24 |
| Low | 11.30 on 10/02/20 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.25 on 04/19/24 | 876.75 on 04/25/24 |
| High | 15.73 on 10/02/20 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | +9.74% since 09/04/20 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -4.41% since 03/25/24 | -7.33% since 03/25/24 |
| Low | 11.00 on 09/24/20 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 15.73 on 10/02/20 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +16.76% since 07/02/20 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -7.50% since 01/25/24 | -6.13% since 01/25/24 |
| Low | 11.00 on 09/24/20 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 17.20 on 08/18/20 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +14.92% since 04/03/20 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +9.55% since 10/25/23 | +11.75% since 10/25/23 |
| Low | 10.50 on 06/26/20 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 17.70 on 05/28/20 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 236,614 | 146,436,016 | 83,519,768 | 103,580,040 | 99,503,640 |
| Shares Outstanding, K | 16,212 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 17,260,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -82,370,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 5,570,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -16,620,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.40 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 11/05/20 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 30.13 | 24.14 |